EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis

Mark Siderius iD, Anneke Spoorenberg iD, Frans G M Kroese, Eveline van der Veer, Suzanne Arends iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0283579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Mark Siderius und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie, Pfizer, UCB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone turnover balance favors bone formation, especially mineralization, during the first 3 years of treatment with TNF-α inhibitors (TNFi). Our aim was to evaluate the course of serum bone turnover markers (BTM) and to investigate if facilitation of mineralization reflected by BTM BALP continues to increase during 6 years of TNFi treatment in patients with ankylosing spondylitis (AS) in daily clinical practice.

Methods

Included were outpatients from the University Medical Center Groningen (UMCG) participating in the Groningen Leeuwarden Axial SpA (GLAS) cohort who were treated with TNFi for at least 6 years. Serum markers of collagen resorption, bone regulation, collagen formation and facilitator of bone mineralization (sCTX, OC, PINP and BALP, respectively) were measured at baseline, 3 and 6 months, 1, 2, 4 and 6 years. Z-scores were calculated to correct for age and gender.

Results

53 AS patients were eligible for analyses (66% male, mean age 39±11 years). Disease activity showed rapid and sustained improvement after start of TNFi. Evaluating BTM, sCTX did not significantly change during 6 years of treatment. OC was only significantly increased at 3 months compared to baseline, with median change in Z-score of +0.5. PINP significantly increased at 3 and 6 months and 2 years of treatment, with maximum median change in Z-score of +0.3. Interestingly, BALP was significantly increased at all time points up to and including 2 years of TNFi treatment, with maximum change in median Z-score of +1.2, and decreased thereafter.

Conclusion

In AS patients receiving long-term TNFi, bone turnover balance favored collagen formation and facilitation of mineralization during the first 2 years of treatment. Thereafter, at 4 and 6 years of follow-up, BTM Z-scores returned to pre-treatment levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingHumansMaleAdultMiddle AgedFemaleTumor Necrosis Factor-alphaCalcification, PhysiologicBone RemodelingBiomarkersTumor Necrosis Factor Inhibitors

Substanzen

Tumor Necrosis Factor-alphaBiomarkersTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Mark Siderius, Anneke Spoorenberg, Suzanne Arends

Förderung

  • AbbVie
  • Pfizer
  • UCB
  • MSD
  • Novartis

Zitieren

APA

Siderius, M., Spoorenberg, A., Kroese, F. G. M., van der Veer, E., & Arends, S. (2023). After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis. PLOS ONE. https://doi.org/10.1371/journal.pone.0283579

Vancouver

Siderius M, Spoorenberg A, Kroese FGM, van der Veer E, Arends S. After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis. PLOS ONE. 2023. doi:10.1371/journal.pone.0283579

BibTeX
@article{Siderius2023,
  author = {Siderius, Mark and Spoorenberg, Anneke and Kroese, Frans G M and van der Veer, Eveline and Arends, Suzanne},
  title = {After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0283579}
}
Kostenlos starten →